Tilray Brands, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Irwin David Simon
- Full Time Employees
- 2,842
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 265 Talbot Street West Leamington ON Canada N8H 5L4
- IPO Date
- Jul 19, 2018
- CIK
- 0001731348
- Website
- tilray.com
- Similar Companies
- Business
- Tilray Brands, Inc. (TLRY) is a global lifestyle consumer products company that researches, cultivates, processes, and distributes medical and adult-use cannabis products; alcoholic and non-alcoholic beverages including craft beers from brands such as Blue Point Brewing Company, Breckenridge Brewery, Green Flash Brewing Company, Redhook Ale Brewery, Shock Top, SweetWater Brewing Company, Widmer Brothers Brewery, Montauk Brewing Company, Alpine Beer Company, and Terrapin Beer Company; hemp-based foods and drinks; energy drinks like HiBall Energy; and wellness products encompassing CBD-infused edibles and other non-combustible cannabis formats. Founded in 2013 and headquartered in New York City with principal operations in Canada including facilities in Nanaimo, British Columbia, the company maintains a global footprint spanning Australia, New Zealand, Latin America including recent approvals in Panama, growing cultivation in Germany and Portugal, and distribution in Europe such as Poland and Italy, alongside U.S. beverage exposure. Tilray serves medical cannabis patients, adult recreational users, and consumer packaged goods markets including craft beer enthusiasts and wellness consumers across its four primary segments of cannabis, beverages, wellness, and distribution. In recent developments, Tilray completed Craft Acquisition II effective September 1, 2024, integrating four additional craft brands and breweries to bolster its beverage portfolio; advanced Project 420 for operational synergies targeting $25 million in cost savings through supply chain optimization, brand investments, and efficiency measures; expanded international medical cannabis access with key regulatory approvals and product launches in Panama, Germany, Italy, and Australia; and launched new products including Delta-9 THC-derived beverages and energy drinks while enhancing distribution networks, particularly in global markets. The company, formed through the 2020 reverse merger with Aphria and subsequent 2023 acquisitions of eight Anheuser-Busch beverage brands for $85 million, continues to diversify beyond cannabis into beverages and wellness amid evolving regulations and market growth. Tilray ranks as the ninth-largest craft beer producer in the U.S. by volume and reports ongoing gross profit increases, with Q2 2025 results showing 29% year-over-year growth to $61 million across all segments.
3 Top Marijuana Stocks to Watch in July 2026
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
Should You Buy Tilray Brands Stock Before July 28?
BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
3 Canadian Marijuana Stocks For Better Investing And Trading 2026
Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on July 28, 2026
BrewDog Waterloo to Host England's Biggest Pub Watch Party for Blockbuster Semifinal
Tilray Medical Announces Commercial Launch of Medical Cannabis in Panama, Expanding Patient Access Across Latin America
Breckenridge Distillery Launches Breck Vodka Seltzer, a Crisp New Ready-to-Drink Line Born in the Rockies
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
Tilray's Stock Is Down Over 50% This Year. Has It Become a Bargain Buy?
Why Tilray Stock Tumbled Last Month
Should You Buy Tilray Stock Before July 15?
Top Canadian Marijuana Stock Picks For Investors Today
Is Tilray a Textbook Value Trap -- or the Most Undervalued Cannabis Stock on the Market?
TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell?
A Revolutionary Technology Narrative Has Surged—Don't Take the Bait
Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights